PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis. Nassar Z.D., H. Moon, T. Duong, L. Neo, M.M. Hill, M. Francois, R.G. Parton, M.O. Parat. Oncotarget, 4(10):1844-1855, 2013 (IF 5.1688). https://www.ncbi.nlm.nih.gov/pubmed/24123650

Caveola-forming proteins caveolin-1 and PTRF in prostate cancer. Nassar Z.D., M.M. Hill, R.G. Parton and M.O. Parat. Nat Rev Urol 10(9):529-36, 2013 (IF 7.735). https://www.ncbi.nlm.nih.gov/pubmed/23938946